Skip to main content

Advertisement

Log in

Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Hidradenitis suppurativa (HS) rarely affects pediatric patients. The literature on pediatric HS patients is scarce. This is a cross-sectional study based on case note review or interviews and clinical examination of 140 pediatric patients undergoing secondary or tertiary level care. Patients were predominantly female (75.5%, n = 105) with a median age of 16. 39% reported 1st-degree relative with HS. Median BMI percentile was 88, and 11% were smokers (n = 15). Median modified Sartorius score was 8.5. Notable comorbidities found were acne (32.8%, n = 45), hirsutism (19.3%, n = 27), and pilonidal cysts (16.4%, n = 23). Resorcinol (n = 27) and clindamycin (n = 25) were the most frequently used topical treatments. Patients were treated with tetracycline (n = 32), or oral clindamycin and rifampicin in combination (n = 29). Surgical excision was performed in 18 patients, deroofing in five and incision in seven patients. Obesity seemed to be prominent in the pediatric population and correlated to parent BMI, suggesting a potential for preventive measures for the family. Disease management appeared to be similar to that of adult HS, bearing in mind that the younger the patient, the milder the disease in majority of cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Azziz R, Carmina E, Sawaya ME (2000) Idiopathic hirsutism. Endocr Rev 21:347–362. https://doi.org/10.1210/edrv.21.4.0401

    Article  CAS  PubMed  Google Scholar 

  2. Bates CR, Buscemi J, Nicholson LM, Cory M, Jagpal A, Bohnert AM (2018) Links between the organization of the family home environment and child obesity: a systematic review. Obes Rev. https://doi.org/10.1111/obr.12662(An official journal of the International Association for the Study of Obesity)

    Article  PubMed  Google Scholar 

  3. Bettoli V, Ricci M, Zauli S, Virgili A (2015) Hidradenitis suppurativa-acne inversa: a relevant dermatosis in paediatric patients. Br J Dermatol 173:1328–1330. https://doi.org/10.1111/bjd.13951

    Article  CAS  PubMed  Google Scholar 

  4. Braunberger TL, Nicholson CL, Gold L, Nahhas AF, Jacobsen G, Parks-Miller A, Hamzavi IH (2018) Hidradenitis suppurativa in children: the Henry Ford experience. Pediatr Dermatol 35:370–373. https://doi.org/10.1111/pde.13466

    Article  PubMed  Google Scholar 

  5. Canoui-Poitrine F, Revuz JE, Wolkenstein P, Viallette C, Gabison G, Pouget F, Poli F, Faye O, Bastuji-Garin S (2009) Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol 61:51–57. https://doi.org/10.1016/j.jaad.2009.02.013

    Article  PubMed  Google Scholar 

  6. de Parades V, Bouchard D, Janier M, Berger A (2013) Pilonidal sinus disease. J Visc Surg 150:237–247. https://doi.org/10.1016/j.jviscsurg.2013.05.006

    Article  PubMed  Google Scholar 

  7. Deckers IE, Janse IC, van der Zee HH, Nijsten T, Boer J, Horvath B, Prens EP (2016) Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): a cross-sectional reference study. J Am Acad Dermatol 75(755–759):e751. https://doi.org/10.1016/j.jaad.2016.04.067

    Article  Google Scholar 

  8. Deckers IE, Kimball AB (2016) The handicap of hidradenitis suppurativa. Dermatol Clin 34:17–22. https://doi.org/10.1016/j.det.2015.07.003

    Article  CAS  PubMed  Google Scholar 

  9. Deckers IE, van der Zee HH, Boer J, Prens EP (2015) Correlation of early-onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement. J Am Acad Dermatol 72:485–488. https://doi.org/10.1016/j.jaad.2014.11.017

    Article  PubMed  Google Scholar 

  10. Dreno B, Poli F, Pawin H, Beylot C, Faure M, Chivot M, Auffret N, Moyse D, Ballanger F, Revuz J (2011) Development and evaluation of a Global Acne Severity Scale (GEA Scale) suitable for France and Europe. J Eur Acad Dermatol Venereol 25:43–48. https://doi.org/10.1111/j.1468-3083.2010.03685.x

    Article  CAS  PubMed  Google Scholar 

  11. Esmann S, Jemec GB (2011) Psychosocial impact of hidradenitis suppurativa: a qualitative study. Acta Derm Venereol 91:328–332. https://doi.org/10.2340/00015555-1082

    Article  PubMed  Google Scholar 

  12. Feito-Rodriguez M, Sendagorta-Cudos E, Herranz-Pinto P, de Lucas-Laguna R (2009) Prepubertal hidradenitis suppurativa successfully treated with botulinum toxin A. Dermatol Surg 35:1300–1302. https://doi.org/10.1111/j.1524-4725.2009.01231.x

    Article  CAS  PubMed  Google Scholar 

  13. Garg A, Kirby JS, Lavian J, Lin G, Strunk A (2017) Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States. JAMA Dermatol 153:760–764. https://doi.org/10.1001/jamadermatol.2017.0201

    Article  PubMed  PubMed Central  Google Scholar 

  14. Garg A, Lavian J, Lin G, Strunk A, Alloo A (2017) Incidence of hidradenitis suppurativa in the United States: a sex- and age-adjusted population analysis. J Am Acad Dermatol 77:118–122. https://doi.org/10.1016/j.jaad.2017.02.005

    Article  PubMed  Google Scholar 

  15. Garg A, Papagermanos V, Midura M, Strunk A (2018) Incidence of hidradenitis suppurativa among tobacco smokers: a population-based retrospective analysis in the USA. Br J Dermatol 178:709–714. https://doi.org/10.1111/bjd.15939

    Article  CAS  PubMed  Google Scholar 

  16. Garg A, Strunk A, Midura M, Papagermanos V, Pomerantz H (2018) Prevalence of hidradenitis suppurativa among patients with Down syndrome: a population-based cross-sectional analysis. Br J Dermatol 178:697–703. https://doi.org/10.1111/bjd.15770

    Article  CAS  PubMed  Google Scholar 

  17. Garg A, Wertenteil S, Baltz R, Strunk A, Finelt N (2018) Prevalence estimates for hidradenitis suppurativa among children and adolescents in the United States: a gender- and age-adjusted population analysis. J Invest Dermatol. https://doi.org/10.1016/j.jid.2018.04.001

    Article  PubMed  PubMed Central  Google Scholar 

  18. Ghodsi SZ, Orawa H, Zouboulis CC (2009) Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. J Invest Dermatol 129:2136–2141. https://doi.org/10.1038/jid.2009.47

    Article  CAS  PubMed  Google Scholar 

  19. Happle R, Konig A (2011) Smoker's boils. Dermatology 222:282–284. https://doi.org/10.1159/000327923

    Article  PubMed  Google Scholar 

  20. Ibler KS, Jemec GB (2013) Cumulative life course impairment in other chronic or recurrent dermatologic diseases. Curr Probl Dermatol 44:130–136. https://doi.org/10.1159/000350056

    Article  PubMed  Google Scholar 

  21. Janse I, Bieniek A, Horvath B, Matusiak L (2016) Surgical procedures in hidradenitis suppurativa. Dermatol Clin 34:97–109. https://doi.org/10.1016/j.det.2015.08.007

    Article  CAS  PubMed  Google Scholar 

  22. Jemec GB (2012) Clinical practice hidradenitis suppurativa. N Engl J Med 366:158–164. https://doi.org/10.1056/NEJMcp1014163

    Article  CAS  PubMed  Google Scholar 

  23. Jemec GB, Kimball AB (2015) Hidradenitis suppurativa: epidemiology and scope of the problem. J Am Acad Dermatol 73:S4–7. https://doi.org/10.1016/j.jaad.2015.07.052

    Article  PubMed  Google Scholar 

  24. Joseph MA, Jayaseelan E, Ganapathi B, Stephen J (2005) Hidradenitis suppurativa treated with finasteride. J Dermatolog Treat 16:75–78. https://doi.org/10.1080/09546630510031403

    Article  CAS  PubMed  Google Scholar 

  25. Kjaersgaard Andersen R, Theut Riis P, Jemec GBE (2018) Factors predicting the self-evaluated health of hidradenitis suppurativa patients recruited from an outpatient clinic. J Eur Acad Dermatol Venereol 32:313–317. https://doi.org/10.1111/jdv.14511

    Article  CAS  PubMed  Google Scholar 

  26. Konig A, Lehmann C, Rompel R, Happle R (1999) Cigarette smoking as a triggering factor of hidradenitis suppurativa. Dermatology 198:261–264. https://doi.org/10.1159/000018126

    Article  CAS  PubMed  Google Scholar 

  27. Koshelev MV, Garrison PA, Wright TS (2014) Concurrent hidradenitis suppurativa, inflammatory acne, dissecting cellulitis of the scalp, and pyoderma gangrenosum in a 16-year-old boy. Pediatr Dermatol 31:e20–21. https://doi.org/10.1111/pde.12196

    Article  PubMed  Google Scholar 

  28. Kromann CB, Deckers IE, Esmann S, Boer J, Prens EP, Jemec GB (2014) Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study. Br J Dermatol 171:819–824. https://doi.org/10.1111/bjd.13090

    Article  CAS  PubMed  Google Scholar 

  29. Kromann CB, Ibler KS, Kristiansen VB, Jemec GB (2014) The influence of body weight on the prevalence and severity of hidradenitis suppurativa. Acta Derm Venereol 94:553–557. https://doi.org/10.2340/00015555-1800

    Article  PubMed  Google Scholar 

  30. Levinson T, Sela T, Chencinski S, Derazne E, Tzur D, Elad H, Kreiss Y (2016) Pilonidal sinus disease: a 10-year review reveals occupational risk factors and the superiority of the minimal surgery trephine technique. Mil Med 181:389–394. https://doi.org/10.7205/MILMED-D-14-00729

    Article  PubMed  Google Scholar 

  31. Lewis F, Messenger AG, Wales JK (1993) Hidradenitis suppurativa as a presenting feature of premature adrenarche. Br J Dermatol 129:447–448

    Article  CAS  Google Scholar 

  32. Liy-Wong C, Pope E, Lara-Corrales I (2015) Hidradenitis suppurativa in the pediatric population. J Am Acad Dermatol 73:S36–41. https://doi.org/10.1016/j.jaad.2015.07.051

    Article  PubMed  Google Scholar 

  33. Mengesha YM, Holcombe TC, Hansen RC (1999) Prepubertal hidradenitis suppurativa: two case reports and review of the literature. Pediatr Dermatol 16:292–296

    Article  CAS  Google Scholar 

  34. Mikkelsen PR, Jemec GB (2014) Hidradenitis suppurativa in children and adolescents: a review of treatment options. Paediatr Drugs 16:483–489. https://doi.org/10.1007/s40272-014-0091-3

    Article  PubMed  Google Scholar 

  35. Miller IM, Ellervik C, Vinding GR, Zarchi K, Ibler KS, Knudsen KM, Jemec GB (2014) Association of metabolic syndrome and hidradenitis suppurativa. JAMA Dermatol 150:1273–1280. https://doi.org/10.1001/jamadermatol.2014.1165

    Article  PubMed  Google Scholar 

  36. Miller IM, McAndrew RJ, Hamzavi I (2016) Prevalence, risk factors, and comorbidities of hidradenitis suppurativa. Dermatol Clin 34:7–16. https://doi.org/10.1016/j.det.2015.08.002

    Article  CAS  PubMed  Google Scholar 

  37. Mota F, Machado S, Selores M (2017) Hidradenitis suppurativa in children treated with finasteride-a case series. Pediatr Dermatol 34:578–583. https://doi.org/10.1111/pde.13216

    Article  PubMed  Google Scholar 

  38. Natarajan B, Sauer C, Shehata B, Kugathasan S (2015) Hidradenitis suppurativa and pediatric Crohn disease. J Pediatr Gastroenterol Nutr 60:e29–30. https://doi.org/10.1097/MPG.0000000000000185

    Article  PubMed  Google Scholar 

  39. Palmer RA, Keefe M (2001) Early-onset hidradenitis suppurativa. Clin Exp Dermatol 26:501–503

    Article  CAS  Google Scholar 

  40. Pink AE, Simpson MA, Desai N, Dafou D, Hills A, Mortimer P, Smith CH, Trembath RC, Barker JNW (2012) Mutations in the gamma-secretase genes NCSTN, PSENEN, and PSEN1 underlie rare forms of hidradenitis suppurativa (acne inversa). J Invest Dermatol 132:2459–2461. https://doi.org/10.1038/jid.2012.162

    Article  CAS  PubMed  Google Scholar 

  41. Prabhu G, Laddha P, Manglani M, Phiske M (2012) Hidradenitis suppurativa in a HIV-infected child. J Postgrad Med 58:207–209. https://doi.org/10.4103/0022-3859.101403

    Article  CAS  PubMed  Google Scholar 

  42. Randhawa HK, Hamilton J, Pope E (2013) Finasteride for the treatment of hidradenitis suppurativa in children and adolescents. JAMA Dermatol 149:732–735. https://doi.org/10.1001/jamadermatol.2013.2874

    Article  PubMed  Google Scholar 

  43. Revuz J (2009) Hidradenitis suppurativa. J Eur Acad Dermatol Venereol 23:985–998. https://doi.org/10.1111/j.1468-3083.2009.03356.x

    Article  CAS  PubMed  Google Scholar 

  44. Santalahti P, Aromaa M, Sourander A, Helenius H, Piha J (2005) Have there been changes in children's psychosomatic symptoms? A 10-year comparison from Finland. Pediatrics 115:e434–442. https://doi.org/10.1542/peds.2004-1261

    Article  PubMed  Google Scholar 

  45. Sartorius K, Emtestam L, Jemec GB, Lapins J (2009) Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol 161:831–839. https://doi.org/10.1111/j.1365-2133.2009.09198.x

    Article  CAS  PubMed  Google Scholar 

  46. Sartorius K, Lapins J, Emtestam L, Jemec GB (2003) Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol 149:211–213

    Article  CAS  Google Scholar 

  47. Scheinfeld N (2015) Hidradenitis suppurativa in prepubescent and pubescent children. Clin Dermatol 33:316–319. https://doi.org/10.1016/j.clindermatol.2014.12.007

    Article  PubMed  Google Scholar 

  48. Schrader AM, Deckers IE, van der Zee HH, Boer J, Prens EP (2014) Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity. J Am Acad Dermatol 71:460–467. https://doi.org/10.1016/j.jaad.2014.04.001

    Article  PubMed  Google Scholar 

  49. Stojkovic-Filipovic JM, Gajic-Veljic MD, Nikolic M (2015) Prepubertal onset of hidradenitis suppurativa in a girl: a case report and literature review. Indian J Dermatol Venereol Leprol 81:294–298. https://doi.org/10.4103/0378-6323.152741

    Article  PubMed  Google Scholar 

  50. Teilmann G, Pedersen CB, Jensen TK, Skakkebaek NE, Juul A (2005) Prevalence and incidence of precocious pubertal development in Denmark: an epidemiologic study based on national registries. Pediatrics 116:1323–1328. https://doi.org/10.1542/peds.2005-0012

    Article  PubMed  Google Scholar 

  51. Theut Riis P, Saunte DM, Benhadou F, Del Marmol V, Guillem P, El-Domyati M, Abdel-Wahab H, Antoniou C, Dessinioti C, Gurer MA, Beksac B, Szepietowski JC, Matusiak L, Emtestam L, Lapins J, Riad H, Doss N, Massa AF, Hamzavi I, Nicholson C, Dolenc-Voljc M, Kim KH, Ohn J, Zouboulis CC, Karagiannidis I, Mokos ZB, Durinec P, Jemec GBE (2018) Low and high body mass index in hidradenitis suppurativa patients-different subtypes? J Eur Acad Dermatol Venereol 32:307–312. https://doi.org/10.1111/jdv.14599

    Article  CAS  PubMed  Google Scholar 

  52. Theut Riis P, Thorlacius L, Knudsen List E, Jemec GBE (2017) A pilot study of unemployment in patients with hidradenitis suppurativa in Denmark. Br J Dermatol 176:1083–1085. https://doi.org/10.1111/bjd.14922

    Article  CAS  PubMed  Google Scholar 

  53. Tiri H, Jokelainen J, Timonen M, Tasanen K, Huilaja L (2018) Somatic and psychiatric comorbidities of hidradenitis suppurativa in children and adolescents. J Am Acad Dermatol. https://doi.org/10.1016/j.jaad.2018.02.067

    Article  PubMed  Google Scholar 

  54. Uzuncakmak TK, Akdeniz N, Karadag AS (2018) Cutaneous manifestations of obesity and the metabolic syndrome. Clin Dermatol 36:81–88. https://doi.org/10.1016/j.clindermatol.2017.09.014

    Article  PubMed  Google Scholar 

  55. Vazquez BG, Alikhan A, Weaver AL, Wetter DA, Davis MD (2013) Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota. J Invest Dermatol 133:97–103. https://doi.org/10.1038/jid.2012.255

    Article  CAS  PubMed  Google Scholar 

  56. Vinding GR, Miller IM, Zarchi K, Ibler KS, Ellervik C, Jemec GB (2014) The prevalence of inverse recurrent suppuration: a population-based study of possible hidradenitis suppurativa. Br J Dermatol 170:884–889. https://doi.org/10.1111/bjd.12787

    Article  CAS  PubMed  Google Scholar 

  57. Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juhasz I, Lapins J, Matusiak L, Prens EP, Revuz J, Schneider-Burrus S, Szepietowski JC, van der Zee HH, Jemec GB (2015) European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol 29:619–644. https://doi.org/10.1111/jdv.12966

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter Theut Riis.

Ethics declarations

Conflict of interest

Gregor B.E. Jemec: Honoraria from AbbVie, Leo pharma, Pierre-Fabre, and Novartis for participation on advisory boards. Grants from Abbvie, Novartis, Regeneron and Leo Pharma for participation as an investigator. Research grants from Abbvie, Leo Pharma and Novartis. Ditte Marie Saunte was paid as a consultant for advisory board meeting by AbbVie, Janssen and Sanofi. She received speaker’s honoraria and/or received grants from the following companies: Bayer, Abbvie, Desitin, Pfizer, Galderma, Astellas, Novartis, Sanofi, and Leo Pharma. José C. Pascual: Honoraria from Abbvie for participation on advisory boards. Jorge Romani: Honoraria from AbbVie, Leo pharma, Almirall and Novartis for participation on advisory boards. Lisa Weibel received honoraria for participation on advisory boards from Sanofi, Merz, and Pierre-Fabre; for participating as study investigator from Abbvie and Novartis; and speaker’s honoraria from Merz, Pierre Fabre, and MEDA Pharma. Philippe Guillem was paid as a consultant for advisory board meeting by AbbVie. He received as speaker’s honoraria from AbbVie, Convatech, and Cicaplus. Axel P Villani received honoraria for participation on advisory boards from Bailleul and Merck. Other Authors stated no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

P.T.R., D.M.S., V.S., A.P.V., J.C.P., D.B., F.B., V.M. and G.B.E.J.: European Reference Network for Rare and Complex Diseases of the Skin (ERN-Skin) member.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Riis, P.T., Saunte, D.M., Sigsgaard, V. et al. Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients. Arch Dermatol Res 312, 715–724 (2020). https://doi.org/10.1007/s00403-020-02053-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-020-02053-6

Keywords

Navigation